SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β-signaling system

Molecular Biology of the Cell

Volumn 14, Issue 10, 2003, Pages 3977-3988

  Schiemann, Barbara J ^a   Neil, Jason R ^b   Schiemann, William P ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CALCIUM BINDING PROTEIN; OSTEONECTIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELL NUCLEUS; CELLS, CULTURED; CLONING, MOLECULAR; DNA REPLICATION; DNA-BINDING PROTEINS; EPITHELIAL CELLS; MICE; MODELS, MOLECULAR; MUTATION; OSTEONECTIN; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; THROMBOSPONDIN 1; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0141541761     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-01-0001     Document Type: Article

References (45)

1. Abreu, J.G., Ketpura, N.I., Reversade, B., and De Robertis, E.M. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat. Cell Biol. 4, 599-604.
2. Bassuk, J.A., et al. (2000). Induction of TGF-β by the matricellular protein SPARC in a rat model of glomerulonephritis. Kidney Int. 57, 117-128.
3. Blobe, G.C., Schiemann, W.P., and Lodish, H.F. (2000). Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358.
4. Boyd, F.T., and Massague, J. (1989). Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem. 264, 2272-2278.
5. Bradshaw, A.D., Francki, A., Motamed, K., Howe, C., and Sage, E.H. (1999). Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol. Biol. Cell 10, 1569-1579.
6. Bradshaw, A.D., and Sage, E.H. (2001). SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Investig. 107, 1049-1054.
7. Crawford, S.E., Stellmach, V., Murphy-Ullrich, J.E., Ribeiro, S.M., Lawler, J., Hynes, R.O., Boivin, G.P., and Bouck, N. (1998). Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93, 1159-1170.
8. Feng, X.H., Filvaroff, E.H., and Derynck, R. (1995). Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 270, 24237-24245.
9. Ford, R., Wang, G., Jannati, P., Adler, D., Racanelli, P., Higgins, P.J., and Staiano-Coico, L. (1993). Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-β-dependent pathway. Exp. Cell Res. 206, 261-275.
10. Francki, A., Bradshaw, A.D., Bassuk, J.A., Howe, C.C., Couser, W.G., and Sage, E.H. (1999). SPARC regulates the expression of collagen type I and transforming growth factor-β1 in mesangial cells. J. Biol. Chem. 274, 32145-32152.
11. Funk, S.E., and Sage, E.H. (1991). The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 2648-2652.
12. Funk, S.E., and Sage, E.H. (1993). Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J. Cell. Physiol. 154, 53-63.
13. Ghaffari, S., Wu, H., Gerlach, M., Han, Y., Lodish, H.F., and Daley, G.Q. (1999). BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells. Proc. Natl. Acad. Sci. USA 96, 13186-13190.
14. Gleizes, P.E., Munger, J.S., Nunes, I., Harpel, J.G., Mazzieri, R., Noguera, I., and Rifkin, D.B. (1997). TGF-β latency: biological significance and mechanisms of activation. Stem Cells 15, 190-197.
15. Hasselaar, P., Loskutoff, D.J., Sawdey, M., and Sage, E.H. (1991). SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J. Biol. Chem. 266, 13178-13184.
16. Hasselaar, P., and Sage, E.H. (1992). SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J. Cell. Biochem. 49, 272-283.
17. Huynh, M.L., Fadok, V.A., and Henson, P.M. (2002). Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41-50.
18. Khalil, N. (1999). TGF-β: from latent to active. Microbes Infect. 1, 1255-1263.
19. Kim, S.J., Angel, P., Lafyatis, R., Hattori, K., Kim, K.Y., Sporn, M.B., Karin, M., and Roberts, A.B. (1990). Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10, 1492-1497.
20. Kupprion, C., Motamed, K., and Sage, E.H. (1998). SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273, 29635-29640.
21. Lane, T.F., Iruela-Arispe, M.L., and Sage, E.H. (1992). Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J. Biol. Chem. 267, 16736-16745.
22. Lane, T.F., and Sage, E.H. (1994). The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163-173.
23. Liu, X., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A., and Lodish, H.F. (1997). Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA 94, 10669-10674.
24. Massague, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791.
25. Motamed, K., Funk, S.E., Koyama, H., Ross, R., Raines, E.W., and Sage, E.H. (2002). Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors. J. Cell. Biochem. 84, 759-771.
26. Motamed, K., and Sage, E.H. (1998). SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J. Cell. Biochem. 70, 543-552.
27. Poczatek, M.H., Hugo, C., Darley-Usmar, V., and Murphy-Ullrich, J.E. (2000). Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1. Am. J. Pathol. 157, 1353-1363.
28. Reddy, K.B., Hocevar, B.A., and Howe, P.H. (1994). Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β1. J. Cell. Biochem. 56, 418-425.
29. Reed, M.J., Vernon, R.B., Abrass, I.B., and Sage, E.H. (1994). TGF-β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J. Cell. Physiol. 158, 169-179.
30. Reynisdottir, I., and Massague, J. (1997). The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11, 492-503.
31. Ribeiro, S.M., Poczatek, M., Schultz-Cherry, S., Villain, M., and Murphy-Ullrich, J.E. (1999). The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J. Biol. Chem. 274, 13586-13593.
32. Sage, E.H. (1992). Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro. Biochem. Cell Biol. 70, 579-592.
33. Sage, E.H. (1997). Terms of attachment: SPARC and tumorigenesis. Nat. Med. 3, 144-146.
34. Sage, E.H., Bassuk, J.A., Yost, J.C., Folkman, M.J., and Lane, T.F. (1995). Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence. J. Cell. Biochem. 57, 127-140.
35. Sage, H., Vernon, R.B., Funk, S.E., Everitt, E.A., and Angello, J. (1989). SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J. Cell Biol. 109, 341-356.
36. Schiemann, W.P., Blobe, G.C., Kalume, D.E., Pandey, A., and Lodish, H.F. (2002). Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion: fibulin-5 is induced by TGF-β and affects protein kinase cascades. J. Biol. Chem. 277, 27367-27377.
37. Schiemann, W.P., Pfeifer, W.M., Levi, E., Kadin, M.E., and Lodish, H.F. (1999). A deletion in the gene for transforming growth factor β type I receptor abolishes growth regulation by transforming growth factor β in a cutaneous T-cell lymphoma. Blood 94, 2854-2861.
38. Shanker, G., Olson, D., Bone, R., and Sawhney, R. (1999). Regulation of extracellular matrix proteins by transforming growth factor β1 in cultured pulmonary endothelial cells. Cell Biol. Int. 23, 61-72.
39. Shiba, H., et al. (1998). Differential effects of various growth factors and cytokines on the syntheses of D.N.A., type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. J. Cell. Physiol. 174, 194-205.
40. Taipale, J., Saharinen, J., and Keski-Oja, J. (1998). Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv. Cancer Res. 75, 87-134.
41. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.F., and Massague, J. (1992). TGF β signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
42. Wrana, J.L., Overall, C.M., and Sodek, J. (1991). Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur. J. Biochem. 197, 519-528.
43. Yan, Q., and Sage, E.H. (1999). SPARC, a matricellular glycoprotein with important biological functions. J. Histochem. Cytochem. 47, 1495-1506.
44. Yost, J.C., and Sage, E.H. (1993). Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand. J. Biol. Chem. 268, 25790-25796.
45. Yue, J., and Mulder, K.M. (2000). Requirement of Ras/MAPK pathway activation by transforming growth factor β for transforming growth factor β1 production in a Smad-dependent pathway. J. Biol. Chem. 275, 30765-30773.